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Introduction
What is sleep, and why do we do it? Surprisingly, some of the main functions of sleep are
relatively unknown. One thing that is known about sleep is that it is vitally important; this can be
assumed from its highly conserved nature across the entire animal kingdom. Proper sleep is
essential for optimal physical and mental health. Sleep disorders impact the brain as well as overall
health in many ways (Capezuti, 2016). Disrupted sleep can be caused by multiple different diseases
and disorders. In today’s 24/7 society, access to technology and availability of entertainment at all
times has contributed to a significant decrease in average sleep time over the past 30 years (Ferrie
et al., 2011). Along with this decrease in average night’s sleep, the prevalence of sleep disorders
in the general population has grown and is continuing to grow at an alarming rate (Ferrie et al.,
2011). As important as sleep is, it is surprising that the purpose and mechanisms behind sleep are
widely unknown. It is imperative to study sleep disturbances and the diseases that are often related
to these disturbances in order to further the understanding of the mechanism of sleep as well as
emphasize the importance of sleep in order to improve the health of society.
One disease that has shown to have
consistent sleep disruptions alongside its main
symptoms is Alzheimer’s Disease. Alzheimer’s
Disease (AD) is a devastating neurodegenerative
disease that is defined by memory and cognition
impairments, and it affects nearly 5.7 million
people in the United States alone (Alzheimer's
Disease: Get The Facts 2020). AD cases have
grown over 145% in the past 20 years, and the
disease is projected to affect 3 times as many
people by the year 2050 (Alz.org: Facts and
Figures). Although the disease is growing in
Figure 1. Illistrational example of amyloid beta plaques and prevalence, little is known about the cause and
neurofibrillary tangles in an AD brain (Amyloid plaques and cure for AD. In an AD brain, the development of
neurofibrillary tangles).
large plaques composed in part of protein
fragments and tangles composed largely of
hyperphosphorylated tau protein are seen, which form the hallmarks of AD – Amyloid plaques
(Aβ) and neurofibrillary tangles. The Aβ protein found in plaques is the result of abnormal
cleavage of a normal, healthy amyloid precursor protein by specific secretases. The Aβ cleavage
can result in different sizes of the protein, including Aβ 40 and Aβ 42. The Aβ peptides can form
soluble oligomers or misfold and aggregate as insoluble plaques that stick to the brain and may
cause a lot of damage to the nerves surrounding them (Schmidt et al., 2009), while other evidence
suggests the soluble oligomers are much more toxic (Yang et al., 2017). These processes
additionally cause neuroinflammation throughout the brain. Figure 1 shows an image of what an
AD brain with Aβ plaques and neurofibrillary tangles looks like compared to a normal, healthy
brain. Nerve damage due to this Aβ plaque build-up as well as neuroinflammation may be a cause
of the severe cognitive decline seen with the development of AD (Schmidt et al., 2009).
The Aβ protein is produced in healthy brains as well, however it is often cleared out of the
brain as a waste product (Yoon et al., 2021). Waste clearance in the brain is believed to occur
during sleep via the glymphatic system; this system’s purpose is to clear soluble proteins and
metabolites from the central nervous system using a network of tunnels within the vascular system

(Jessen et al., 2015). Lack of sleep could therefore influence Aβ clearance in the brain. AD patients
have often been shown to have disrupted sleep symptoms associated with their disease. Previous
research has shown up to 40% of people suffering from AD also show sleep disruption along with
the hallmark cognitive symptoms (Lloret et al., 2020). The sleep pattern of an AD patient is often
fragmented with frequent nighttime awakening and daytimes naps (Lloret et al., 2020). Due to this
disrupted sleep and decreased availability for waste clearance from the brain, these sleep
symptoms may be a contributing factor in the progression of AD. Previous studies have indicated
that alterations in the daily sleep-wake cycle precede the diagnosis of AD by many years (Bliwise,
2004). A role for sleep disruption in AD pathology has also been supporting sleep mouse models
of AD, which accelerates various pathological markers. However, these studies did not mimic the
sleep disruption patterns found in people with AD. Therefore, the first goal of this research was to
investigate whether the disrupting sleep patterns 4 times/day would provide a better model of AD
patients, and the role disrupted sleep might play in the progression of disease itself. This
experiment investigated whether chronic disruption of daily sleep-wake cycles with sleep
fragmentation increased Aβ 40 and 42 levels and neuroinflammation in the brains of transgenic
AD mice (3xTgAD). The 3xTgAD mice express 3 mutations, the PS1m146v, APPSwe, and tauP301L
transgenes, that are associated with familial, early-onset AD, causing expression of Aβ plaques
and tau pathology (Sterniczuk et al., 2010). While mice sleep differently than people, with highly
polyphasic sleep, and a majority of sleep during the light period, they are still good models for
sleep studies because sleep disruptions in rodents show comparable cognitive impairments to
humans after sleep disruption, and the basic neurophysiology of sleep is very similar across all
mammals. The hypothesis for this study was that sleep fragmentation will increase Aβ 40 and 42
levels as well as neuroinflammation in the brain when compared to the non-sleep fragmented group
of transgenic 3xTgAD mice.
If sleep fragmentation may lead to greater progression of AD, then increasing sleep amount
or quality may help slow the progression of AD. Often times pharmaceuticals are used to help
patients who suffer from sleep disorders, but those come along with undesirable side effects and
have not been shown to treat the underlying sleep disorder (Pagel & Parnes, 2001). Another option
for sleep enhancement is using mechanical movement. This idea stems from the common way that
parents help their babies go to sleep with gentle rocking. Similarly, many people tend to doze off
in a car or on a boat due to the nature of slight, consistent movement. Is this phenomenon of rocking
inducing sleep scientifically sound and significant? This phenomenon has only just recently been
observed in rodents; rodents do not typically rock their young to sleep, but the idea is that the
movement could mimic movements of the mother when the babies are in utero. Due to the high
similarities between mouse and human sleep and overall physiology, could a mouse model show
improved sleep after mechanical rocking? These are the questions that inspired the next research
question of this project.
The scientific basis behind gentle rocking and sleep lies in the vestibular system, which is
located in the ear with the main purpose of detecting linear and angular motion of the head as well
as orientation and perception (Besnard et al., 2018). The vestibular organs have direct inputs into
the suprachiasmatic nucleus (SCN), which is known as the master circadian clock in the brain with
large influences on sleep/wake cycles of both humans and mice (Besnard et al., 2018).
Additionally, the vestibular organs play an important role in synchronizing the fluctuations of body
temperature seen among biological rhythms (Besnard et al., 2018). So, when the vestibular organs
sense a consistent, light movement, these signals are believed to be transmitted to the SCN and
influence sleep (Besnard et al., 2018). A previous study found that gentle rocking using a

mechanical rocking platform may help consolidate sleep using a mouse model (Kompotis et al.,
2019). The study by Kompotis and colleagues used a rocking platform at multiple different
frequencies to investigate how this method could be used to improve sleep in mice. This current
study aimed to investigate whether mechanical rocking could be used to improve sleep using a
mouse model, and whether this method would be successful in helping slow the progression of
AD. The hypothesis of this experiment was that slight rocking using a shaker platform will improve
sleep in mice, and that improved sleep will slow the progression of AD pathology in the brain.
Methods
Sleep Fragmentation Study
For this experiment, 8-month-old female 3xTgAD mice were used as the model. Only
female mice were used in this study due to females expressing a more consistent phenotype as well
as the ease of being able to re-group house females without fear of injury from fighting. Mice were
kept in standard group housing with four mice to a cage during the protocol, except for weeks 1
and 4 when sleep monitoring required each mouse to be housed individually. The light conditions
were standard 12:12, with lights on at 7:00 AM and lights off at 7 PM. All mice were given
standard mouse chow and water ad libitum throughout the entire protocol.
Sleep was monitored using the PiezoSleep System (Signal Solutions LLC). The PiezoSleep
system consists of piezoelectric films placed underneath the floor of the mouse cage (Figure 2).
These films detect changes in pressure caused by movement and change these pressures into
electrical signals that can be analyzed to detect sleep. The system is precise enough to detect
breathing and has been shown to have a classification accuracy of >90% (Mang et al., 2014). This
option was chosen as it is less invasive than the standard surgery to insert EEG connection in the
brain.
Mice were sorted into two separated groups: a sleep
fragmentation group (SF) and an undisturbed sleep
group (US). Both groups consisted of 8 mice each. The
protocol was 4 weeks long. During the first and fourth
weeks, mice were kept in individual cages equipped
with piezoelectric sensors in order to monitor sleep and
sleep disruption. During the second and third weeks,
mice were group housed with no sleep monitoring.
The sleep fragmentation group underwent four oneFigure 2. The piezoelectric films used to record sleep
for both the sleep fragmentation and sleep
hour sleep fragmentation sessions each day, five days a
enhancement studies (www.sigsoln.com).
week, for four weeks. During weeks two and three, SF
mice were removed from group housing and placed in
novel, individual cages for the sleep fragmentation sessions and then placed back into group
housing immediately after the sleep fragmentation sessions concluded. The one-hour sleep
fragmentation sessions consisted of keeping the mice awake by introducing novel toys such as
Legos or cardboard tubes and using a paintbrush to lightly disturb them. The US group mice were
left undisturbed during the sleep fragmentation intervals. After the four-week protocol, all mice
were anesthetized using CO2 asphyxiation and brains were harvested after decapitation. The
hippocampus and cortex of the brains were extracted and stored frozen at -80°C.
Brain matter was analyzed for Aβ 40 and 42 levels and neuroinflammatory markers (reactive
microglial, reactive astrocytes, inflammatory cytokines, and inflammatory chemokines). Aβ 40

and 42 levels were quantified using sandwich ELISAs, using two different assay buffers,
radioimmunoprecipitation assay buffer (RIPA) and 0.2% diethylamine (DEA). RIPA buffer was
used to measure aggregated and protofibrillar Aβ, while the DEA buffer measured diffusible Aβ
monomers and oligomers. Neuroinflammatory markers were quantified using RNeasy mini
columns as well as High-Capacity cDNA Reverse Transcription Kits. Sleep data was collected
from the piezoelectric system in 30-minute bins. For each 30-minute interval, the percent sleep
was recorded as an average of that 30-minute bin. Data was analyzed using GraphPad Prism and
2-way repeated measures ANOVA by group and time.
Sleep Enhancement Study
For this experiment, three seven-month-old C57/BL6 (commonly referred to as black
6) mice were used as the model. One mouse that was used was a male and the other two were
female. All mice were kept on a 12:12 light dark schedule (lights on 7:00 AM – 7:00 PM) in
standard group housing with standard mouse chow and water ad libitum. The protocol was
performed on the mice one at a time. During the four-day experiment, the mouse was housed
individually in a cage equipped with piezoelectric system film (Signal Solutions LLC) and placed
upon the MouseQwake platform (Signal Solutions LLC). The set-up of the cages was as follows:
the MouseQwake platform rested on a shelf, with a piezoelectric film directly on top of it, and then
the standard mouse cage with food and water placed on top of the film. A large rubber band was
used to secure the cage to the MouseQwake platform to ensure that nothing fell out of place while
the platform was rocking. Additionally, a metal water bottle stand was screwed into the base of
the MouseQwake platform to ensure that the rocking wouldn’t cause the water bottle to leak.
For the four-day protocol, the first day was an acclimation day where the mouse was placed
into the experimental cage set-up and no data was analyzed. The second day was a baseline day,
where no rocking occurred, and the recording began at lights on (7:00 AM). Day three was the
experimental day. The MouseQwake platform rocked from 7:00 AM-7:00 PM at 2 Hz frequency
and 30 m amplitude. The last day, day four, was a recovery day where no rocking occurred, and
the data analysis ended at 7:00 AM the next morning. Each mouse’s tail was then marked using
sharpie before returning it to group housing after the four-day protocol was complete. Sleep data
was analyzed in 60-minute bins, with average total percent sleep for the 60-minute interval
recorded. Sleep stats and GraphPad Prism were used to statistically analyze data (2-way ANOVA)
and create graphs.
Results
Sleep Fragmentation Study
Results from the piezoelectric monitoring showed that sleep/wake patterns were
successfully altered using the sleep fragmentation sessions. Total sleep percent was significantly
reduced during the one-hour sleep fragmentation sessions (p<0.01). Figure 3 illustrates the average
percent sleep for each hour on week one and week four. During week one, light phase sleep for
the SF group was significantly decreased compared to US; however, week one dark phase sleep
was not significantly affected. In contrast, during week four, light phase sleep as well as dark phase
sleep was significantly altered for the SF group compared to the US group. Additionally, during
week four, mice had a higher percent sleep during the sleep fragmentation intervals. Sleep bout
duration was also affected by the sleep fragmentation intervals. During both week one and week
four, sleep bout durations were significantly decreased when compared to the US decreased. Sleep

bout length as well as sleep
percent was increased
during the dark phase for
the SF group compared to
US.
Results from the
ELISA analysis showed
that the SF mice trended to
having higher levels of
both protein sizes in the
hippocampus. However,
only the Aβ 42 in the RIPA
buffer produced significant
results in the hippocampus.
Chronic SF significantly
increased the hippocampal
levels of RIPA-soluble Aβ
40 by 20% and Aβ 42 by
64% (significance p<0.05)
when compared to US. The
DEA-soluble Aβ 40 and 42
did
not
produce
significance. This is shown
in Figure 4. For the cortex,
Figure 3. Chronic sleep fragmentation alters the daily sleep profile. Values represent the data trended higher
the mean + S.E.M. sleep percentage for 30 min bins, N=8/group, for piezoelectric
levels in the SF group
recordings during weeks 1 and 4. Horizontal white and black bars at the bottom
however none of the results
indicate the light and dark phases.
were significant.
Analysis of neuroinflammation markers showed higher levels in the hippocampus of the
SF group compared to US, however this result was not statistically significant. Figure 5 shows the
composite z-score for reactive microglial, reactive astrocytes, inflammatory cytokines, and
inflammatory chemokines in the hippocampus and neocortex.
Sleep Enhancement Study
Results from the three trials of sleep enhancement of the MouseQwake platform showed
that slight rocking did not increase percent sleep or sleep bout lengths. Table 1 shows the average
percent sleep values for baseline, experimental, and recovery days. A small trend can be seen that
shows slightly less percent sleep during the light phase on the experimental day (when the shaker
was rocking the mouse) and then slightly more sleep during the dark phase after the shaker is
turned off. Figure 6 shows the total sleep across all three days as well as the average light and dark
phase sleep percent averaged over the three days. There was no significant difference between the
percent sleep for baseline, experimental, and recovery. There was a trend towards a greater amount
of dark phase sleep during the experimental day.

Discussion
Sleep Fragmentation Study
This study established that the
3xTgAD mouse provides a good model
for the disrupted sleep/wake patterns
demonstrated in AD patients. The
findings of this study show that the sleep
fragmentation sessions successfully
reduced sleep percent during the SF
intervals. Overall, it was found that
protein levels of Aβ 40 and 42 as well as
neuroinflammation markers in the
hippocampus were significantly higher
in SF mice, leading to the progression of
AD neuropathology. Decreased sleep
and shortened/fragmented sleep cycles
may play a role in limiting the amount
of Aβ 40 and 42 cleared from the brain,
resulting in increased Aβ deposition and
neuroinflammation in the brain,
especially in the hippocampus.

Figure 4. Aβ 40 and 42 levels in RIPA and DEA buffers for the cortex and
hippocampus. Approximately a 100-fold difference was found between the
cortex and hippocampus. Vertical bars represent mean +/-SEM. Significance
was found for Aβ 42 in RIPA buffer (p<0.05).

Few
previous
studies
have
investigated how sleep fragmentation alters
daily sleep patterns. The one-hour sleep
fragmentation intervals used in this study are
comparable to the frequent nighttime
awakenings experienced by AD patients,
more so than previous sleep deprivation
studies. The results from the sleep data
showed that by week four, SF mice had
altered sleep in the dark phase as well as light
phase, indicating that the sleep fragmentation
sessions altered the sleep/wake patterns.
Figure 5. Relative change ( z-score) of neuroinflammatory markers. These findings also suggested that the SF
Red is SF and black in US. A significant result was found for reactive group experienced longer sleep bouts during
microglial signature (p=0.0461).
the dark phase during recovery sleep in
response to chronic sleep fragmentation. During week four, a greater percent sleep was observed
during the sleep fragmentation session when compared to week one. This indicated that the SF
mice were having a harder time staying awake during the sleep fragmentation sessions, especially
towards the end of the light phase, demonstrating the cumulative effects of four weeks of chronic
sleep fragmentation. Although the overall reduced total sleep that AD patients often experience
was not seen in this mouse model, the sleep fragmentation protocol did mimic the fragmented
nature of the human AD patient’s sleep pattern.
Analysis of Aβ 40 and 42 showed increases from both buffers in the hippocampus of the
SF mice compared to the US mice. However, only the RIPA soluble Aβ 42 in the hippocampus

was significant. A longer sleep fragmentation protocol may be useful to produce significant results
for the DEA buffer and RIPA Aβ 40, as AD is a disease that accumulates over many years. These
results suggest that continuing the study for a longer period of time may cause additional Aβ buildup and therefore produce more significant results. Additionally, the Aβ 42 protein has been shown
to have greater neurotoxicity in the brain, so it may be more influential in the progression of
cognitive symptoms associated with AD (Schmidt et al., 2009).
The neuroinflammatory markers were found in higher levels in the brains of SF mice,
indicating that more damage to neurons were causing greater inflammation as a result of chronic
sleep fragmentation. These results suggest that chronic sleep fragmentation as well as greater
levels of Aβ drive inflammation. Although results showed trends toward higher levels of
neuroinflammation markers, there was a large amount of variability between subjects within both
groups. So, more trials with larger sample sizes may help make stronger conclusions about
neuroinflammatory markers and AD pathology.
This study had some limitations. Only female mice were used, and this could be an issue
because male and female mice tend to have different sleep profiles. Another limitation is that only
the 3xTgAD transgenic model was investigated; other transgenic AD mouse models, such as the
APP mouse model would be useful to investigate using this same protocol. Additionally, only
hippocampal and cortex Aβ and neuroinflammatory levels were measured. AD pathology comes
along with other defects in the brain such as neurofibrillary tangles, neuronal death, and cognitive
impairments. These hallmarks of AD were not studied in this experiment, so the effect of chronic
sleep fragmentation on these facets remain unknown. Another potential limitation is the use of the
piezoelectric system. Although this system has the advantage of being non-invasive, the ability to
study different phases of sleep such as REM and slow wave sleep are lost by using this method.
Altogether, the 3xTgAD mouse model provides a model that mimics AD patient when
exposed to chronic sleep fragmentation. Chronic sleep fragmentation, as seen in AD patients,
stimulates greater accumulation of Aβ as well as neuroinflammation in the hippocampus of the
brain. Future rodent studies could utilize both sexes and other AD models, with larger sample
sizes, and analyzing other aspects of AD such as memory and cognition as well as neuronal death
would be beneficial to furthering the understanding of the relationship between sleep and AD. If
these future rodent studies continue to support the findings from this experiment, then sleep
enhancement and consolidation may be a potential therapeutic method for slowing the progression
of AD pathology.
Sleep Enhancement Study
Since it was found that sleep fragmentation expedited the development of AD pathologies
in the brain, this study aimed to explore whether sleep enhancement could be used to slow the
progression of AD pathology in the brain. First, a sleep enhancement method must be determined.
This experiment intended to determine if slight rocking using a mechanical shaker platform,
MouseQwake, could improve the sleep of C57/BL6 mice. Significant alterations of sleep were not
found when using the mechanical shaker. Due to the very small sample size (n=3) used for this
experiment, limited conclusions can be made. The continuation of this experiment with a larger
sample size is crucial in order to fully understand the relationship between slight rocking and sleep

Light phase sleep
Dark phase sleep
Total sleep

Baseline
53.8%
31.0%
42.4%

Experimental
52.9%
32.2%
42.6%

Recovery
56.4%
27.9%
42.1%

Table 1. This table shows the average percent sleep values for all three days of the protocol (n=3).
improvement. A very small trend can be observed in the data, showing that the recovery day had
slightly increased amounts of light phase sleep and slightly less dark phase sleep. This may indicate
that the slight rocking from the MouseQwake platform caused a slight sleep disruption for the
mouse, leading to greater amounts of light phase sleep on the third recovery day. The slight
increase in dark phase sleep after the 12 hours of rocking may also indicate sleep recovery from
disruption due to the shaker.

Figure 6. This figure shows the percent sleep values across the three days. No significant results were found.
Although, the recovery day trended to have greater light phase sleep and less dark phase sleep.

A previous study, by Kompotis et al. in 2019, found significant improvement in sleep when
using mechanical rocking on mice. This studied used lateral mechanical rocking of twenty-three
C57BL/6J mice monitored using EEG. This studied explored multiple different frequencies but
found that 1 Hz and greater had the most significant impact on sleep structure. This study found
that slight rocking, which influences the body’s vestibular system, has a significant impact on
improving NREM sleep. The vestibular system is known to project directly to the brain’s central

circadian clock, the SCN. So, this mechanism of action should have a huge influence on the body’s
daily sleep/wake cycles.
The failure to find significant results for this study may be attributed to the fact that this
experiment did not look at NREM and REM sleep cycles, but only sleep percent and mean sleep
bout length as a whole. Perhaps the total sleep time and sleep bouts were unaffected, however the
theta waves in NREM may have increased. This was not measured using the piezo system, so this
would be something important to investigate with future studies. Another limitation to this study
was that mice with sleep disorders to begin with were not studied. The sleep percentages recorded
for the mice were relatively average for a normal, healthy mouse. Unfortunately, a good mouse
model for insomnia or any other sleep disorder has not yet been discovered. A mouse that already
experiences healthy sleep may be difficult to try to use when trying to improve sleep. If the mouse
is already obtaining normal levels of sleep, then increasing that sleep amount may be difficult.
Another drawback to this experiment was the equipment used. This MouseQwake system
was a prototype, and this was the first time it was used for this application. The exact frequency
was slightly off, so the desired frequency had to be felt by hand which may be off due to human
error. Additionally, every 30 seconds, the shaker “hiccupped” slightly, causing a very slight
inconsistency in its rocking. This slight blip may have been enough to disturb a resting mouse’s
sleep. Additionally, the equipment made a slight humming noise that may have disturbed the
mouse in an otherwise quiet environment.
Additional trials will be conducted in order to further the results of this study. Since the
current protocol did not successfully show sleep enhancement, future plans to alter the frequency
(2 Hz) and amplitude (30 m) settings used are in place in order to investigate whether different
frequencies/amplitudes may help improve sleep. Slight rocking may be sleep enhancing, but only
at the correct settings. Studies that have found successful sleep enhancement with a shaking device
(ex. Kompotis et al., 2019) have used a platform that uses lateral movement in order to have a
more “true rocking” motion, whereas the platform used in this current experiment used vibrations
to induce the simulation of shaking. So, it is important to continue this experiment using different
settings as well as reducing the noise of the equipment and any other confounding variables that
may be affecting sleep. If changing the amplitude and frequency of the shaker is not proven
successful, then possibly introducing a new type of mechanical device that allows for horizontal
and vertical movement, in order to create a true rocking motion, would be beneficial. The future
goal of this study is to successfully enhance sleep using mechanical rocking and test to see if
enhanced sleep from mechanical rocking can slow the progression of AD pathology using
transgenic 3xTgAD mouse models.
Reflection
Participation in this research project has been a huge learning experience for me. First
and foremost, I have learned about the process of real-life science: trial and error, success and
failure. Not that I would consider my sleep enhancement trials a failure, but I did learn how to
adapt and ask new questions when the expected or desired results did not occur. I have learned to
critically think and create my own protocol rather than simply follow one that already existed.
The lessons I have learned from conducting research are ones I will carry with me throughout my
future education and career. I want to thank all of my professors and advisors that have helped
me achieve my goals throughout my undergraduate career. I want to specially thank my research
mentors, Dr. Bruce O’Hara, Dr. Marilyn Duncan, and (soon to be Dr.) Ren Guerriero, for all the
time, effort, and advice they have given me over the past 3 years.
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